203 related articles for article (PubMed ID: 34304441)
21. Overexpression of ICAM-1 Predicts Poor Survival in High-Grade Serous Ovarian Carcinoma: A Study Based on TCGA and GEO Databases and Tissue Microarray.
Wang S; Yin C; Zhang Y; Zhang L; Tao L; Liang W; Pang L; Fu R; Ding Y; Li F; Jia W
Biomed Res Int; 2019; 2019():2867372. PubMed ID: 31312656
[TBL] [Abstract][Full Text] [Related]
22. [The expression and significance of protease activated receptor 2 in ovarian epithelial carcinoma].
Liu SH; Ma YM; Zhang YN; Zhao XH; Wang HY; Li B
Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):64-73. PubMed ID: 36709122
[No Abstract] [Full Text] [Related]
23. Identification of Prognostic Biomarkers Among FAM83 Family Genes in Human Ovarian Cancer Through Bioinformatic Analysis and Experimental Verification.
Lin S; Du J; Hao J; Luo X; Wu H; Zhang H; Zhao X; Xu L; Wang B
Cancer Manag Res; 2021; 13():8611-8627. PubMed ID: 34815715
[TBL] [Abstract][Full Text] [Related]
24. Insulin-like growth factor 2 mRNA-binding protein 2 is a therapeutic target in ovarian cancer.
Yuan J; Li X; Wang F; Liu H; Guan W; Xu G
Exp Biol Med (Maywood); 2023 Dec; 248(23):2198-2209. PubMed ID: 38084732
[TBL] [Abstract][Full Text] [Related]
25. Molecular Analysis of Prognosis and Immune Infiltration of Ovarian Cancer Based on Homeobox D Genes.
Chen B; Gao C; Wang H; Sun J; Han Z
Comput Math Methods Med; 2022; 2022():3268386. PubMed ID: 36213580
[TBL] [Abstract][Full Text] [Related]
26. Cancer Stem Cell Markers-Clinical Relevance and Prognostic Value in High-Grade Serous Ovarian Cancer (HGSOC) Based on The Cancer Genome Atlas Analysis.
Iżycka N; Zaborowski MP; Ciecierski Ł; Jaz K; Szubert S; Miedziarek C; Rezler M; Piątek-Bajan K; Synakiewicz A; Jankowska A; Figlerowicz M; Sterzyńska K; Nowak-Markwitz E
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628927
[TBL] [Abstract][Full Text] [Related]
27. Aberrant expression of ADAM9 in ovarian cancer and its clinical significance.
Guo T; Yuan D; Lin M; Zhu D; Xu N; Wang J
J Clin Lab Anal; 2020 Apr; 34(4):e23136. PubMed ID: 31793719
[TBL] [Abstract][Full Text] [Related]
28. Low Expression of SLC7A11 Confers Drug Resistance and Worse Survival in Ovarian Cancer
Ke Y; Chen X; Su Y; Chen C; Lei S; Xia L; Wei D; Zhang H; Dong C; Liu X; Yin F
Front Oncol; 2021; 11():744940. PubMed ID: 34790572
[TBL] [Abstract][Full Text] [Related]
29. The enhancer RNA ADCY10P1 is associated with the progression of ovarian cancer.
Mo J; Zhang L; Li H; Duan H; Wang D; Zhao X; Xie Y
J Ovarian Res; 2022 May; 15(1):61. PubMed ID: 35568893
[TBL] [Abstract][Full Text] [Related]
30. Cross-validation of genes potentially associated with overall survival and drug resistance in ovarian cancer.
Gao Y; Liu X; Li T; Wei L; Yang A; Lu Y; Zhang J; Li L; Wang S; Yin F
Oncol Rep; 2017 May; 37(5):3084-3092. PubMed ID: 28350120
[TBL] [Abstract][Full Text] [Related]
31. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
Zhao Q; Fan C
BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
[TBL] [Abstract][Full Text] [Related]
32. [Expression and significance of PD-1 and PD-L1 in the specimens of epithelial ovarian cancer].
Ju C; Gao JC; Zhang PX; Zhang KN; Yang S; Kang TJ; Zhao HZ; Qi WJ; Zhang QP; Kong FD; Guan HW; Shi H
Zhonghua Fu Chan Ke Za Zhi; 2020 Aug; 55(8):529-534. PubMed ID: 32854477
[No Abstract] [Full Text] [Related]
33. [Identification and prognostic value of differentially expressed proteins of patients with platinum resistance epithelial ovarian cancer in serum].
Wu WJ; Wang Q; Zhang W; Li L
Zhonghua Fu Chan Ke Za Zhi; 2016 Jul; 51(7):515-23. PubMed ID: 27465871
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis.
Long X; Song K; Hu H; Tian Q; Wang W; Dong Q; Yin X; Di W
J Exp Clin Cancer Res; 2019 Aug; 38(1):345. PubMed ID: 31391118
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Significance of the CXCLs and Its Impact on the Immune Microenvironment in Ovarian Cancer.
Gu C; Xiong X; Liu W
Dis Markers; 2023; 2023():5223657. PubMed ID: 36798787
[TBL] [Abstract][Full Text] [Related]
36. Biological and prognostic value of ETV5 in high-grade serous ovarian cancer.
Zhang L; Fu R; Liu P; Wang L; Liang W; Zou H; Jia W; Tao L
J Ovarian Res; 2021 Nov; 14(1):149. PubMed ID: 34736492
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y
Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423
[TBL] [Abstract][Full Text] [Related]
38. Relationship between HER2 and JAK/STAT-SOCS3 signaling pathway and clinicopathological features and prognosis of ovarian cancer.
Shang AQ; Wu J; Bi F; Zhang YJ; Xu LR; Li LL; Chen FF; Wang WW; Zhu JJ; Liu YY
Cancer Biol Ther; 2017 May; 18(5):314-322. PubMed ID: 28448787
[TBL] [Abstract][Full Text] [Related]
39. Adenylate kinase 7 is a prognostic indicator of overall survival in ovarian cancer.
Zhang XY; Zhou LL; Jiao Y; Li YQ; Guan YN; Zhao YC; Zheng LW
Medicine (Baltimore); 2021 Jan; 100(1):e24134. PubMed ID: 33429787
[TBL] [Abstract][Full Text] [Related]
40. CACNA1C is a prognostic predictor for patients with ovarian cancer.
Chang X; Dong Y
J Ovarian Res; 2021 Jul; 14(1):88. PubMed ID: 34210324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]